Going Concern (worsened) — Auditor opinion for FY2025 continues to include going-concern explanatory paragraph; company lacks 12-month liquidity from March 2026 financial statement issuance despite extending runway to Q4 2026.

NASDAQ: SNGX SOLIGENIX, INC. 10-K

Soligenix reports 34% loss increase to $11.1M; completes BD trial, extends cash to Q4 2026

Filed March 31, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 21, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SNGX commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 11:00 PM